Cargando…
High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
Transcriptional reprogramming contributes to the progression and recurrence of cancer. However, the poorly elucidated mechanisms of transcriptional reprogramming in tumors make the development of effective drugs difficult, and gene expression signature is helpful for connecting genetic information a...
Autores principales: | Huang, Lijun, Yi, Xiaohong, Yu, Xiankuo, Wang, Yumei, Zhang, Chen, Qin, Lixia, Guo, Dale, Zhou, Shiyi, Zhang, Guanbin, Deng, Yun, Bao, Xilinqiqige, Wang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518531/ https://www.ncbi.nlm.nih.gov/pubmed/34660328 http://dx.doi.org/10.3389/fonc.2021.762023 |
Ejemplares similares
-
Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy
por: Alkhilaiwi, Faris
Publicado: (2021) -
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021) -
Taohong Siwu Decoction exerts anticancer effects on breast cancer via regulating MYC, BIRC5, EGF and PIK3R1 revealed by HTS(2) technology
por: Gui, Yu, et al.
Publicado: (2022) -
Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression
por: Zboril, Emily, et al.
Publicado: (2021) -
Editorial: Discovery of small molecule lead compounds: A driving force to unravel new anticancer targets and mechanisms
por: Zhang, Yan, et al.
Publicado: (2023)